November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering Marc de GaridelCEO at AbivaxSpeaker
Profile
Marc deGaridel is a biotechnology entrepreneur. He has been CEO of Abivax since 2023, building it into a global biotechnology success story by 2025. He led Cincor Pharma between 2020 and 2023, which was sold to Astra Zeneca. He led Corvidia Therapeutics between 2018 and 2020, which was sold to Novo Nordisk. Between 2010 and 2016, he was CEO of Ipsen and is now non-executive chairman of the group's board of directors. He previously worked at Amgen and Eli Lilly in multiple countries. He is an ESTP engineer, holds a master's degree in international management and an executive MBA from Harvard.
Agenda Sessions
Vision & value: The Sofinnova–Abivax crescendo
, 14:30View Session